ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 16 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $457,473 | -39.9% | 1,270,758 | 0.0% | 0.17% | -30.2% |
Q3 2022 | $761,000 | +21.0% | 1,270,758 | 0.0% | 0.24% | +2.5% |
Q2 2022 | $629,000 | -45.0% | 1,270,758 | 0.0% | 0.24% | -37.6% |
Q1 2022 | $1,143,000 | -19.7% | 1,270,758 | 0.0% | 0.38% | -11.9% |
Q4 2021 | $1,423,000 | -37.1% | 1,270,758 | 0.0% | 0.43% | -40.5% |
Q3 2021 | $2,262,000 | -53.9% | 1,270,758 | -14.6% | 0.72% | -41.0% |
Q2 2021 | $4,912,000 | +1.2% | 1,488,508 | +2.8% | 1.22% | +24.0% |
Q1 2021 | $4,853,000 | +90.4% | 1,448,508 | +4.0% | 0.98% | +88.7% |
Q4 2020 | $2,549,000 | -2.6% | 1,392,654 | +1.1% | 0.52% | +0.8% |
Q3 2020 | $2,616,000 | -5.0% | 1,376,954 | 0.0% | 0.52% | -35.6% |
Q2 2020 | $2,754,000 | +108.5% | 1,376,954 | +6.3% | 0.80% | +81.5% |
Q1 2020 | $1,321,000 | -36.1% | 1,294,911 | +27.2% | 0.44% | -10.0% |
Q4 2019 | $2,066,000 | – | 1,017,971 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,498,192 | $1,678,000 | 0.68% |
TANG CAPITAL MANAGEMENT LLC | 2,054,925 | $2,302,000 | 0.46% |
Sio Capital Management, LLC | 1,270,758 | $1,423,000 | 0.43% |
DAFNA Capital Management LLC | 732,500 | $820,000 | 0.21% |
Vivo Capital, LLC | 2,840,909 | $3,182,000 | 0.19% |
MANGROVE PARTNERS IM, LLC | 2,514,576 | $2,816,000 | 0.17% |
SABBY MANAGEMENT, LLC | 899,850 | $1,008,000 | 0.15% |
Waterfront Wealth Inc. | 270,000 | $302,000 | 0.12% |
Knott David M Jr | 230,251 | $258,000 | 0.09% |
RTW INVESTMENTS, LP | 3,250,000 | $3,640,000 | 0.05% |